APA

Selinger C. P., Lenti M. V., Clark T., Rafferty H., Gracie D., Ford A. C., OʼConnor A., Ahmad T. & Hamlin P. J. (20180730). Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. : Inflammatory bowel diseases.

Chicago

Selinger Christian P, Lenti Marco V, Clark Tanya, Rafferty Helen, Gracie David, Ford Alexander C, OʼConnor Anthony, Ahmad Tariq and Hamlin P John. 20180730. Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. : Inflammatory bowel diseases.

Harvard

Selinger C. P., Lenti M. V., Clark T., Rafferty H., Gracie D., Ford A. C., OʼConnor A., Ahmad T. and Hamlin P. J. (20180730). Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. : Inflammatory bowel diseases.

MLA

Selinger Christian P, Lenti Marco V, Clark Tanya, Rafferty Helen, Gracie David, Ford Alexander C, OʼConnor Anthony, Ahmad Tariq and Hamlin P John. Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. : Inflammatory bowel diseases. 20180730.